跳至主要内容
临床试验/NCT06561438
NCT06561438已完成3 期

Postoperative Pain Management Following Laparoscopic Cholecystectomy- Vortioxetine

Future University in Egypt1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2024年8月6日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
86
试验地点
1
主要终点
VAS score (Visual analogue scale)

研究概览

简要总结

Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain. No. study has investigated Vortioxetine as an adjuvant to standard care for postoperative pain management in patients undergoing LC

详细描述

Postoperative pain is a main challenge for delayed hospital discharge in Laparoscopic cholecystectomy. . Postoperative pain management is essential and the inability to treat acute pain appropriately in the first 48 postoperative hours represents a risk factor for developing chronic pain. Vortioxetine (VO) is a multimodal serotonergic antidepressant with a unique mechanism of action that is effective in treating neuropathic pain. The purpose of this study is evaluating the efficacy and tolerability of preoperative oral administration of Vortioxetine on postoperative pain control in patients undergoing LC

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are scheduled to undergo elective LC.
  • Adults (males and/or females) between the ages of 18-70 years old.

排除标准

  • Chronic pain other than cholelithiasis.
  • Patients who received analgesics or sedatives 24 h before scheduled surgery.
  • Severe hepatic (Child Pugh Class B and C) and renal dysfunction (CrCl <30ml/min)
  • Previous allergic response to vortioxetine.
  • Pregnancy and lactation
  • Patients with communication problems, cognitive dysfunction, or psychological disorders
  • Daily corticosteroid use

研究组 & 干预措施

Intervention arm

Experimental

20 mg oral vortioxetine tablet 2 hours before the procedure

干预措施: Vortioxetine 20Mg Tab (Drug)

结局指标

主要结局

VAS score (Visual analogue scale)

时间窗: 2 hours, 4 hours, 8 hours, 12 hours, 24 hours

Pain intensity: VAS score from 0 to 100 mm In which 0 means no pain, and 100 means the worst pain possible

次要结局

  • Time to analgesic request(24 hours)
  • Quality of life (QoL) after laparoscopic cholecystectomy (LC)(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hoda Mohamed

Principal investigator

Future University in Egypt

研究点 (1)

Loading locations...

相似试验

Postoperative Pain Management Following Laparoscopic... | 临床试验